nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—systemic lupus erythematosus—Pregabalin—epilepsy syndrome	0.153	0.535	CpDpCtD
Acetylsalicylic acid—systemic lupus erythematosus—Gabapentin—epilepsy syndrome	0.0878	0.307	CpDpCtD
Acetylsalicylic acid—Salsalate—Carbamazepine—epilepsy syndrome	0.0687	0.52	CrCrCtD
Acetylsalicylic acid—Salsalate—Oxcarbazepine—epilepsy syndrome	0.0633	0.48	CrCrCtD
Acetylsalicylic acid—CYP2C19—epilepsy syndrome	0.0546	0.369	CbGaD
Acetylsalicylic acid—rheumatoid arthritis—Gabapentin—epilepsy syndrome	0.0453	0.158	CpDpCtD
Acetylsalicylic acid—PTGS2—epilepsy syndrome	0.034	0.23	CbGaD
Acetylsalicylic acid—ALB—epilepsy syndrome	0.0303	0.205	CbGaD
Acetylsalicylic acid—ABCB1—epilepsy syndrome	0.0289	0.196	CbGaD
Acetylsalicylic acid—SLC22A7—Valproic Acid—epilepsy syndrome	0.0107	0.0435	CbGbCtD
Acetylsalicylic acid—ALB—Oxcarbazepine—epilepsy syndrome	0.0103	0.042	CbGbCtD
Acetylsalicylic acid—ALB—Fosphenytoin—epilepsy syndrome	0.00904	0.0367	CbGbCtD
Acetylsalicylic acid—ALB—Clonazepam—epilepsy syndrome	0.00818	0.0332	CbGbCtD
Acetylsalicylic acid—CYP2C8—Trimethadione—epilepsy syndrome	0.00743	0.0302	CbGbCtD
Acetylsalicylic acid—CYP2C8—Fosphenytoin—epilepsy syndrome	0.00699	0.0284	CbGbCtD
Acetylsalicylic acid—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00671	0.0273	CbGbCtD
Acetylsalicylic acid—ALB—Rufinamide—epilepsy syndrome	0.00667	0.0271	CbGbCtD
Acetylsalicylic acid—PTGS1—Diazepam—epilepsy syndrome	0.00659	0.0268	CbGbCtD
Acetylsalicylic acid—CYP2C19—Trimethadione—epilepsy syndrome	0.00623	0.0253	CbGbCtD
Acetylsalicylic acid—CYP2C19—Felbamate—epilepsy syndrome	0.00623	0.0253	CbGbCtD
Acetylsalicylic acid—SLC22A6—Acetazolamide—epilepsy syndrome	0.0061	0.0248	CbGbCtD
Acetylsalicylic acid—ABCB1—Levetiracetam—epilepsy syndrome	0.00592	0.024	CbGbCtD
Acetylsalicylic acid—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00586	0.0238	CbGbCtD
Acetylsalicylic acid—ALB—Phenytoin—epilepsy syndrome	0.00583	0.0237	CbGbCtD
Acetylsalicylic acid—ALB—Propofol—epilepsy syndrome	0.00543	0.0221	CbGbCtD
Acetylsalicylic acid—PTGS1—Valproic Acid—epilepsy syndrome	0.0052	0.0211	CbGbCtD
Acetylsalicylic acid—CYP2C9—Trimethadione—epilepsy syndrome	0.00518	0.0211	CbGbCtD
Acetylsalicylic acid—CYP2C19—Clobazam—epilepsy syndrome	0.00508	0.0207	CbGbCtD
Acetylsalicylic acid—CYP2C8—Carbamazepine—epilepsy syndrome	0.00502	0.0204	CbGbCtD
Acetylsalicylic acid—ALB—Diazepam—epilepsy syndrome	0.00492	0.02	CbGbCtD
Acetylsalicylic acid—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00487	0.0198	CbGbCtD
Acetylsalicylic acid—CYP2C8—Primidone—epilepsy syndrome	0.00469	0.019	CbGbCtD
Acetylsalicylic acid—SLC22A6—Valproic Acid—epilepsy syndrome	0.00456	0.0185	CbGbCtD
Acetylsalicylic acid—CYP2C8—Phenytoin—epilepsy syndrome	0.0045	0.0183	CbGbCtD
Acetylsalicylic acid—CYP2C19—Carbamazepine—epilepsy syndrome	0.00421	0.0171	CbGbCtD
Acetylsalicylic acid—CYP2C8—Propofol—epilepsy syndrome	0.0042	0.0171	CbGbCtD
Acetylsalicylic acid—ABCB1—Clobazam—epilepsy syndrome	0.0041	0.0167	CbGbCtD
Acetylsalicylic acid—CYP2C8—Phenobarbital—epilepsy syndrome	0.00401	0.0163	CbGbCtD
Acetylsalicylic acid—ABCB1—Lamotrigine—epilepsy syndrome	0.00395	0.016	CbGbCtD
Acetylsalicylic acid—CYP2C19—Primidone—epilepsy syndrome	0.00393	0.016	CbGbCtD
Acetylsalicylic acid—CYP2C8—Diazepam—epilepsy syndrome	0.0038	0.0155	CbGbCtD
Acetylsalicylic acid—CYP2C19—Phenytoin—epilepsy syndrome	0.00378	0.0154	CbGbCtD
Acetylsalicylic acid—CYP2C19—Propofol—epilepsy syndrome	0.00352	0.0143	CbGbCtD
Acetylsalicylic acid—CYP2C9—Carbamazepine—epilepsy syndrome	0.0035	0.0142	CbGbCtD
Acetylsalicylic acid—ABCB1—Carbamazepine—epilepsy syndrome	0.0034	0.0138	CbGbCtD
Acetylsalicylic acid—CYP2C19—Phenobarbital—epilepsy syndrome	0.00337	0.0137	CbGbCtD
Acetylsalicylic acid—CYP2C9—Primidone—epilepsy syndrome	0.00327	0.0133	CbGbCtD
Acetylsalicylic acid—CYP2C19—Diazepam—epilepsy syndrome	0.00319	0.013	CbGbCtD
Acetylsalicylic acid—CYP2C9—Phenytoin—epilepsy syndrome	0.00314	0.0128	CbGbCtD
Acetylsalicylic acid—CYP2C19—Zonisamide—epilepsy syndrome	0.00312	0.0127	CbGbCtD
Acetylsalicylic acid—ABCB1—Phenytoin—epilepsy syndrome	0.00305	0.0124	CbGbCtD
Acetylsalicylic acid—CYP2C8—Valproic Acid—epilepsy syndrome	0.003	0.0122	CbGbCtD
Acetylsalicylic acid—CYP2C9—Propofol—epilepsy syndrome	0.00293	0.0119	CbGbCtD
Acetylsalicylic acid—CYP2C9—Phenobarbital—epilepsy syndrome	0.0028	0.0114	CbGbCtD
Acetylsalicylic acid—TP53—skull—epilepsy syndrome	0.0028	0.0911	CbGeAlD
Acetylsalicylic acid—ABCB1—Phenobarbital—epilepsy syndrome	0.00272	0.011	CbGbCtD
Acetylsalicylic acid—TP53—forelimb—epilepsy syndrome	0.00269	0.0877	CbGeAlD
Acetylsalicylic acid—ABCB1—Midazolam—epilepsy syndrome	0.00268	0.0109	CbGbCtD
Acetylsalicylic acid—CYP2C9—Diazepam—epilepsy syndrome	0.00265	0.0108	CbGbCtD
Acetylsalicylic acid—ABCB1—Diazepam—epilepsy syndrome	0.00258	0.0105	CbGbCtD
Acetylsalicylic acid—CYP2C19—Valproic Acid—epilepsy syndrome	0.00252	0.0102	CbGbCtD
Acetylsalicylic acid—CYP2C19—Topiramate—epilepsy syndrome	0.00227	0.00923	CbGbCtD
Acetylsalicylic acid—CYP2C9—Valproic Acid—epilepsy syndrome	0.00209	0.0085	CbGbCtD
Acetylsalicylic acid—HSPA5—ganglion—epilepsy syndrome	0.0014	0.0457	CbGeAlD
Acetylsalicylic acid—TP53—hindbrain—epilepsy syndrome	0.0011	0.0359	CbGeAlD
Acetylsalicylic acid—NFKBIA—hindbrain—epilepsy syndrome	0.00109	0.0354	CbGeAlD
Acetylsalicylic acid—HSPA5—hindbrain—epilepsy syndrome	0.00106	0.0346	CbGeAlD
Acetylsalicylic acid—Meclofenamic acid—KCNQ2—epilepsy syndrome	0.000708	0.394	CrCbGaD
Acetylsalicylic acid—Meclofenamic acid—KCNQ3—epilepsy syndrome	0.000708	0.394	CrCbGaD
Acetylsalicylic acid—TP53—brainstem—epilepsy syndrome	0.000632	0.0206	CbGeAlD
Acetylsalicylic acid—NFKBIA—brainstem—epilepsy syndrome	0.000622	0.0203	CbGeAlD
Acetylsalicylic acid—TP53—forebrain—epilepsy syndrome	0.00061	0.0199	CbGeAlD
Acetylsalicylic acid—HSPA5—brainstem—epilepsy syndrome	0.000609	0.0198	CbGeAlD
Acetylsalicylic acid—NFKBIA—forebrain—epilepsy syndrome	0.0006	0.0196	CbGeAlD
Acetylsalicylic acid—HSPA5—forebrain—epilepsy syndrome	0.000588	0.0192	CbGeAlD
Acetylsalicylic acid—TP53—telencephalon—epilepsy syndrome	0.000561	0.0183	CbGeAlD
Acetylsalicylic acid—NFKBIA—telencephalon—epilepsy syndrome	0.000552	0.018	CbGeAlD
Acetylsalicylic acid—TP53—Bortezomib—Lacosamide—epilepsy syndrome	0.00055	0.484	CbGdCrCtD
Acetylsalicylic acid—HSPA5—telencephalon—epilepsy syndrome	0.000541	0.0176	CbGeAlD
Acetylsalicylic acid—RPS6KA3—forebrain—epilepsy syndrome	0.000501	0.0163	CbGeAlD
Acetylsalicylic acid—RPS6KA3—telencephalon—epilepsy syndrome	0.000461	0.015	CbGeAlD
Acetylsalicylic acid—NFKBIA—medulla oblongata—epilepsy syndrome	0.000434	0.0141	CbGeAlD
Acetylsalicylic acid—HSPA5—medulla oblongata—epilepsy syndrome	0.000425	0.0138	CbGeAlD
Acetylsalicylic acid—NFKBIA—midbrain—epilepsy syndrome	0.000397	0.0129	CbGeAlD
Acetylsalicylic acid—TP53—spinal cord—epilepsy syndrome	0.000393	0.0128	CbGeAlD
Acetylsalicylic acid—HSPA5—midbrain—epilepsy syndrome	0.000388	0.0126	CbGeAlD
Acetylsalicylic acid—NFKBIA—spinal cord—epilepsy syndrome	0.000387	0.0126	CbGeAlD
Acetylsalicylic acid—HSPA5—spinal cord—epilepsy syndrome	0.000379	0.0123	CbGeAlD
Acetylsalicylic acid—RPS6KA3—medulla oblongata—epilepsy syndrome	0.000362	0.0118	CbGeAlD
Acetylsalicylic acid—TP53—head—epilepsy syndrome	0.000349	0.0114	CbGeAlD
Acetylsalicylic acid—NFKBIA—head—epilepsy syndrome	0.000344	0.0112	CbGeAlD
Acetylsalicylic acid—IKBKB—telencephalon—epilepsy syndrome	0.00034	0.0111	CbGeAlD
Acetylsalicylic acid—HSPA5—head—epilepsy syndrome	0.000337	0.011	CbGeAlD
Acetylsalicylic acid—TP53—nervous system—epilepsy syndrome	0.000331	0.0108	CbGeAlD
Acetylsalicylic acid—RPS6KA3—midbrain—epilepsy syndrome	0.000331	0.0108	CbGeAlD
Acetylsalicylic acid—NFKBIA—nervous system—epilepsy syndrome	0.000326	0.0106	CbGeAlD
Acetylsalicylic acid—RPS6KA3—spinal cord—epilepsy syndrome	0.000323	0.0105	CbGeAlD
Acetylsalicylic acid—HSPA5—nervous system—epilepsy syndrome	0.000319	0.0104	CbGeAlD
Acetylsalicylic acid—TP53—central nervous system—epilepsy syndrome	0.000319	0.0104	CbGeAlD
Acetylsalicylic acid—NFKBIA—central nervous system—epilepsy syndrome	0.000314	0.0102	CbGeAlD
Acetylsalicylic acid—TP53—cerebellum—epilepsy syndrome	0.000312	0.0102	CbGeAlD
Acetylsalicylic acid—NFKBIA—Chlorprothixene—Midazolam—epilepsy syndrome	0.000309	0.273	CbGdCrCtD
Acetylsalicylic acid—HSPA5—central nervous system—epilepsy syndrome	0.000307	0.01	CbGeAlD
Acetylsalicylic acid—NFKBIA—cerebellum—epilepsy syndrome	0.000307	0.00999	CbGeAlD
Acetylsalicylic acid—HSPA5—cerebellum—epilepsy syndrome	0.0003	0.00979	CbGeAlD
Acetylsalicylic acid—EDNRA—medulla oblongata—epilepsy syndrome	0.000294	0.00958	CbGeAlD
Acetylsalicylic acid—PTGS1—ganglion—epilepsy syndrome	0.000293	0.00955	CbGeAlD
Acetylsalicylic acid—RPS6KA3—head—epilepsy syndrome	0.000287	0.00934	CbGeAlD
Acetylsalicylic acid—NFKBIA—Chlorprothixene—Diazepam—epilepsy syndrome	0.000276	0.243	CbGdCrCtD
Acetylsalicylic acid—RPS6KA3—nervous system—epilepsy syndrome	0.000272	0.00886	CbGeAlD
Acetylsalicylic acid—EDNRA—midbrain—epilepsy syndrome	0.000269	0.00876	CbGeAlD
Acetylsalicylic acid—RPS6KA3—central nervous system—epilepsy syndrome	0.000262	0.00853	CbGeAlD
Acetylsalicylic acid—RPS6KA3—cerebellum—epilepsy syndrome	0.000256	0.00833	CbGeAlD
Acetylsalicylic acid—TP53—brain—epilepsy syndrome	0.000253	0.00825	CbGeAlD
Acetylsalicylic acid—NFKBIA—brain—epilepsy syndrome	0.000249	0.00812	CbGeAlD
Acetylsalicylic acid—HSPA5—brain—epilepsy syndrome	0.000244	0.00795	CbGeAlD
Acetylsalicylic acid—IKBKB—head—epilepsy syndrome	0.000212	0.0069	CbGeAlD
Acetylsalicylic acid—RPS6KA3—brain—epilepsy syndrome	0.000208	0.00677	CbGeAlD
Acetylsalicylic acid—IKBKB—nervous system—epilepsy syndrome	0.000201	0.00654	CbGeAlD
Acetylsalicylic acid—IKBKB—central nervous system—epilepsy syndrome	0.000193	0.0063	CbGeAlD
Acetylsalicylic acid—IKBKB—cerebellum—epilepsy syndrome	0.000189	0.00615	CbGeAlD
Acetylsalicylic acid—EDNRA—brain—epilepsy syndrome	0.000169	0.0055	CbGeAlD
Acetylsalicylic acid—IKBKB—brain—epilepsy syndrome	0.000153	0.005	CbGeAlD
Acetylsalicylic acid—SLC22A7—brain—epilepsy syndrome	0.000149	0.00485	CbGeAlD
Acetylsalicylic acid—SLC22A6—brain—epilepsy syndrome	0.000144	0.00468	CbGeAlD
Acetylsalicylic acid—PTGS1—forebrain—epilepsy syndrome	0.000123	0.00401	CbGeAlD
Acetylsalicylic acid—PTGS2—forebrain—epilepsy syndrome	0.000118	0.00383	CbGeAlD
Acetylsalicylic acid—PTGS1—telencephalon—epilepsy syndrome	0.000113	0.00368	CbGeAlD
Acetylsalicylic acid—PTGS2—telencephalon—epilepsy syndrome	0.000108	0.00352	CbGeAlD
Acetylsalicylic acid—Salicylate-sodium—PTGS2—epilepsy syndrome	0.000107	0.0594	CrCbGaD
Acetylsalicylic acid—ALB—brain—epilepsy syndrome	8.96e-05	0.00292	CbGeAlD
Acetylsalicylic acid—PTGS2—medulla oblongata—epilepsy syndrome	8.5e-05	0.00277	CbGeAlD
Acetylsalicylic acid—PTGS1—spinal cord—epilepsy syndrome	7.93e-05	0.00258	CbGeAlD
Acetylsalicylic acid—PTGS2—midbrain—epilepsy syndrome	7.76e-05	0.00253	CbGeAlD
Acetylsalicylic acid—PTGS2—spinal cord—epilepsy syndrome	7.58e-05	0.00247	CbGeAlD
Acetylsalicylic acid—ABCB1—forebrain—epilepsy syndrome	7.27e-05	0.00237	CbGeAlD
Acetylsalicylic acid—PTGS1—head—epilepsy syndrome	7.04e-05	0.00229	CbGeAlD
Acetylsalicylic acid—PTGS2—head—epilepsy syndrome	6.73e-05	0.00219	CbGeAlD
Acetylsalicylic acid—ABCB1—telencephalon—epilepsy syndrome	6.69e-05	0.00218	CbGeAlD
Acetylsalicylic acid—PTGS1—nervous system—epilepsy syndrome	6.68e-05	0.00218	CbGeAlD
Acetylsalicylic acid—PTGS1—central nervous system—epilepsy syndrome	6.43e-05	0.00209	CbGeAlD
Acetylsalicylic acid—PTGS2—nervous system—epilepsy syndrome	6.38e-05	0.00208	CbGeAlD
Acetylsalicylic acid—CYP2C8—brain—epilepsy syndrome	6.29e-05	0.00205	CbGeAlD
Acetylsalicylic acid—Salsalate—PTGS2—epilepsy syndrome	6.22e-05	0.0346	CrCbGaD
Acetylsalicylic acid—PTGS2—central nervous system—epilepsy syndrome	6.15e-05	0.002	CbGeAlD
Acetylsalicylic acid—Meclofenamic acid—PTGS2—epilepsy syndrome	6.13e-05	0.0341	CrCbGaD
Acetylsalicylic acid—PTGS2—cerebellum—epilepsy syndrome	6.01e-05	0.00196	CbGeAlD
Acetylsalicylic acid—ABCB1—medulla oblongata—epilepsy syndrome	5.25e-05	0.00171	CbGeAlD
Acetylsalicylic acid—PTGS1—brain—epilepsy syndrome	5.1e-05	0.00166	CbGeAlD
Acetylsalicylic acid—Dyspnoea—Oxcarbazepine—epilepsy syndrome	5.09e-05	0.000655	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Clonazepam—epilepsy syndrome	5.08e-05	0.000654	CcSEcCtD
Acetylsalicylic acid—Somnolence—Oxcarbazepine—epilepsy syndrome	5.07e-05	0.000653	CcSEcCtD
Acetylsalicylic acid—Nausea—Clobazam—epilepsy syndrome	5.07e-05	0.000653	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Phenytoin—epilepsy syndrome	5.05e-05	0.00065	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Felbamate—epilepsy syndrome	5.05e-05	0.000649	CcSEcCtD
Acetylsalicylic acid—Dizziness—Acetazolamide—epilepsy syndrome	5.03e-05	0.000647	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Levetiracetam—epilepsy syndrome	5.03e-05	0.000647	CcSEcCtD
Acetylsalicylic acid—Urticaria—Diazepam—epilepsy syndrome	5.03e-05	0.000646	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Oxcarbazepine—epilepsy syndrome	5.02e-05	0.000646	CcSEcCtD
Acetylsalicylic acid—Pruritus—Propofol—epilepsy syndrome	5e-05	0.000643	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Pregabalin—epilepsy syndrome	4.99e-05	0.000642	CcSEcCtD
Acetylsalicylic acid—Flushing—Pregabalin—epilepsy syndrome	4.97e-05	0.000639	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Zonisamide—epilepsy syndrome	4.94e-05	0.000635	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Gabapentin—epilepsy syndrome	4.91e-05	0.000631	CcSEcCtD
Acetylsalicylic acid—Pruritus—Midazolam—epilepsy syndrome	4.89e-05	0.00063	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Carbamazepine—epilepsy syndrome	4.88e-05	0.000628	CcSEcCtD
Acetylsalicylic acid—PTGS2—brain—epilepsy syndrome	4.88e-05	0.00159	CbGeAlD
Acetylsalicylic acid—Somnolence—Carbamazepine—epilepsy syndrome	4.87e-05	0.000626	CcSEcCtD
Acetylsalicylic acid—Urticaria—Felbamate—epilepsy syndrome	4.86e-05	0.000626	CcSEcCtD
Acetylsalicylic acid—Vomiting—Acetazolamide—epilepsy syndrome	4.84e-05	0.000623	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Propofol—epilepsy syndrome	4.84e-05	0.000622	CcSEcCtD
Acetylsalicylic acid—Pruritus—Levetiracetam—epilepsy syndrome	4.83e-05	0.000622	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Carbamazepine—epilepsy syndrome	4.82e-05	0.00062	CcSEcCtD
Acetylsalicylic acid—ABCB1—midbrain—epilepsy syndrome	4.8e-05	0.00156	CbGeAlD
Acetylsalicylic acid—Mefenamic acid—PTGS2—epilepsy syndrome	4.77e-05	0.0265	CrCbGaD
Acetylsalicylic acid—Anaemia—Valproic Acid—epilepsy syndrome	4.76e-05	0.000613	CcSEcCtD
Acetylsalicylic acid—Urticaria—Zonisamide—epilepsy syndrome	4.76e-05	0.000612	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Clonazepam—epilepsy syndrome	4.76e-05	0.000612	CcSEcCtD
Acetylsalicylic acid—Agitation—Valproic Acid—epilepsy syndrome	4.74e-05	0.000609	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Vigabatrin—epilepsy syndrome	4.73e-05	0.000609	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Phenytoin—epilepsy syndrome	4.73e-05	0.000608	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Lamotrigine—epilepsy syndrome	4.72e-05	0.000607	CcSEcCtD
Acetylsalicylic acid—Angioedema—Valproic Acid—epilepsy syndrome	4.71e-05	0.000606	CcSEcCtD
Acetylsalicylic acid—Somnolence—Lamotrigine—epilepsy syndrome	4.71e-05	0.000605	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	4.7e-05	0.000605	CcSEcCtD
Acetylsalicylic acid—ABCB1—spinal cord—epilepsy syndrome	4.69e-05	0.00153	CbGeAlD
Acetylsalicylic acid—Dizziness—Propofol—epilepsy syndrome	4.68e-05	0.000601	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Levetiracetam—epilepsy syndrome	4.67e-05	0.000601	CcSEcCtD
Acetylsalicylic acid—Pruritus—Fosphenytoin—epilepsy syndrome	4.66e-05	0.0006	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Diazepam—epilepsy syndrome	4.66e-05	0.0006	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Lamotrigine—epilepsy syndrome	4.66e-05	0.000599	CcSEcCtD
Acetylsalicylic acid—Vertigo—Valproic Acid—epilepsy syndrome	4.63e-05	0.000596	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Valproic Acid—epilepsy syndrome	4.61e-05	0.000593	CcSEcCtD
Acetylsalicylic acid—Urticaria—Clonazepam—epilepsy syndrome	4.59e-05	0.00059	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Gabapentin—epilepsy syndrome	4.58e-05	0.000589	CcSEcCtD
Acetylsalicylic acid—Dizziness—Midazolam—epilepsy syndrome	4.57e-05	0.000588	CcSEcCtD
Acetylsalicylic acid—Urticaria—Phenytoin—epilepsy syndrome	4.56e-05	0.000586	CcSEcCtD
Acetylsalicylic acid—Pruritus—Vigabatrin—epilepsy syndrome	4.55e-05	0.000585	CcSEcCtD
Acetylsalicylic acid—Urticaria—Oxcarbazepine—epilepsy syndrome	4.53e-05	0.000583	CcSEcCtD
Acetylsalicylic acid—Nausea—Acetazolamide—epilepsy syndrome	4.52e-05	0.000582	CcSEcCtD
Acetylsalicylic acid—Dizziness—Levetiracetam—epilepsy syndrome	4.52e-05	0.000581	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Carbamazepine—epilepsy syndrome	4.51e-05	0.000581	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Fosphenytoin—epilepsy syndrome	4.51e-05	0.00058	CcSEcCtD
Acetylsalicylic acid—Vomiting—Propofol—epilepsy syndrome	4.5e-05	0.000578	CcSEcCtD
Acetylsalicylic acid—Pruritus—Diazepam—epilepsy syndrome	4.48e-05	0.000576	CcSEcCtD
Acetylsalicylic acid—Rash—Propofol—epilepsy syndrome	4.46e-05	0.000573	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Propofol—epilepsy syndrome	4.45e-05	0.000573	CcSEcCtD
Acetylsalicylic acid—Hypertension—Valproic Acid—epilepsy syndrome	4.45e-05	0.000572	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Zonisamide—epilepsy syndrome	4.42e-05	0.000568	CcSEcCtD
Acetylsalicylic acid—Vomiting—Midazolam—epilepsy syndrome	4.4e-05	0.000566	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Vigabatrin—epilepsy syndrome	4.4e-05	0.000566	CcSEcCtD
Acetylsalicylic acid—Chest pain—Valproic Acid—epilepsy syndrome	4.39e-05	0.000564	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Valproic Acid—epilepsy syndrome	4.39e-05	0.000564	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Lamotrigine—epilepsy syndrome	4.36e-05	0.000561	CcSEcCtD
Acetylsalicylic acid—Rash—Midazolam—epilepsy syndrome	4.36e-05	0.000561	CcSEcCtD
Acetylsalicylic acid—Dizziness—Fosphenytoin—epilepsy syndrome	4.36e-05	0.000561	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Midazolam—epilepsy syndrome	4.36e-05	0.00056	CcSEcCtD
Acetylsalicylic acid—Urticaria—Carbamazepine—epilepsy syndrome	4.35e-05	0.00056	CcSEcCtD
Acetylsalicylic acid—Vomiting—Levetiracetam—epilepsy syndrome	4.34e-05	0.000559	CcSEcCtD
Acetylsalicylic acid—Pruritus—Felbamate—epilepsy syndrome	4.33e-05	0.000557	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Diazepam—epilepsy syndrome	4.33e-05	0.000557	CcSEcCtD
Acetylsalicylic acid—Rash—Levetiracetam—epilepsy syndrome	4.31e-05	0.000554	CcSEcCtD
Acetylsalicylic acid—Anaemia—Pregabalin—epilepsy syndrome	4.31e-05	0.000554	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Levetiracetam—epilepsy syndrome	4.3e-05	0.000553	CcSEcCtD
Acetylsalicylic acid—Agitation—Pregabalin—epilepsy syndrome	4.28e-05	0.000551	CcSEcCtD
Acetylsalicylic acid—Angioedema—Pregabalin—epilepsy syndrome	4.26e-05	0.000548	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Clonazepam—epilepsy syndrome	4.26e-05	0.000547	CcSEcCtD
Acetylsalicylic acid—Dizziness—Vigabatrin—epilepsy syndrome	4.25e-05	0.000547	CcSEcCtD
Acetylsalicylic acid—Confusional state—Valproic Acid—epilepsy syndrome	4.24e-05	0.000546	CcSEcCtD
Acetylsalicylic acid—Pruritus—Zonisamide—epilepsy syndrome	4.24e-05	0.000545	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Phenytoin—epilepsy syndrome	4.23e-05	0.000544	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Valproic Acid—epilepsy syndrome	4.21e-05	0.000541	CcSEcCtD
Acetylsalicylic acid—Urticaria—Lamotrigine—epilepsy syndrome	4.21e-05	0.000541	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	4.21e-05	0.000541	CcSEcCtD
Acetylsalicylic acid—Nausea—Propofol—epilepsy syndrome	4.2e-05	0.00054	CcSEcCtD
Acetylsalicylic acid—Vomiting—Fosphenytoin—epilepsy syndrome	4.19e-05	0.000539	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Felbamate—epilepsy syndrome	4.19e-05	0.000539	CcSEcCtD
Acetylsalicylic acid—Vertigo—Pregabalin—epilepsy syndrome	4.19e-05	0.000538	CcSEcCtD
Acetylsalicylic acid—Dizziness—Diazepam—epilepsy syndrome	4.18e-05	0.000538	CcSEcCtD
Acetylsalicylic acid—Syncope—Pregabalin—epilepsy syndrome	4.18e-05	0.000537	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Pregabalin—epilepsy syndrome	4.17e-05	0.000536	CcSEcCtD
Acetylsalicylic acid—ABCB1—head—epilepsy syndrome	4.16e-05	0.00136	CbGeAlD
Acetylsalicylic acid—Rash—Fosphenytoin—epilepsy syndrome	4.16e-05	0.000535	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Fosphenytoin—epilepsy syndrome	4.15e-05	0.000534	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Topiramate—epilepsy syndrome	4.15e-05	0.000534	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Topiramate—epilepsy syndrome	4.13e-05	0.000531	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Valproic Acid—epilepsy syndrome	4.12e-05	0.00053	CcSEcCtD
Acetylsalicylic acid—Nausea—Midazolam—epilepsy syndrome	4.11e-05	0.000529	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Valproic Acid—epilepsy syndrome	4.11e-05	0.000528	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Zonisamide—epilepsy syndrome	4.1e-05	0.000528	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Pregabalin—epilepsy syndrome	4.1e-05	0.000527	CcSEcCtD
Acetylsalicylic acid—Pruritus—Clonazepam—epilepsy syndrome	4.09e-05	0.000526	CcSEcCtD
Acetylsalicylic acid—Vomiting—Vigabatrin—epilepsy syndrome	4.09e-05	0.000526	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Valproic Acid—epilepsy syndrome	4.07e-05	0.000523	CcSEcCtD
Acetylsalicylic acid—Pruritus—Phenytoin—epilepsy syndrome	4.06e-05	0.000522	CcSEcCtD
Acetylsalicylic acid—Nausea—Levetiracetam—epilepsy syndrome	4.06e-05	0.000522	CcSEcCtD
Acetylsalicylic acid—Rash—Vigabatrin—epilepsy syndrome	4.05e-05	0.000521	CcSEcCtD
Acetylsalicylic acid—Dizziness—Felbamate—epilepsy syndrome	4.05e-05	0.000521	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Vigabatrin—epilepsy syndrome	4.05e-05	0.000521	CcSEcCtD
Acetylsalicylic acid—Pruritus—Oxcarbazepine—epilepsy syndrome	4.04e-05	0.000519	CcSEcCtD
Acetylsalicylic acid—Convulsion—Pregabalin—epilepsy syndrome	4.04e-05	0.000519	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Carbamazepine—epilepsy syndrome	4.04e-05	0.000519	CcSEcCtD
Acetylsalicylic acid—Hypertension—Pregabalin—epilepsy syndrome	4.02e-05	0.000517	CcSEcCtD
Acetylsalicylic acid—Vomiting—Diazepam—epilepsy syndrome	4.02e-05	0.000517	CcSEcCtD
Acetylsalicylic acid—Rash—Diazepam—epilepsy syndrome	3.99e-05	0.000513	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Diazepam—epilepsy syndrome	3.99e-05	0.000513	CcSEcCtD
Acetylsalicylic acid—Chest pain—Pregabalin—epilepsy syndrome	3.97e-05	0.00051	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Pregabalin—epilepsy syndrome	3.97e-05	0.00051	CcSEcCtD
Acetylsalicylic acid—Dizziness—Zonisamide—epilepsy syndrome	3.96e-05	0.00051	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Clonazepam—epilepsy syndrome	3.95e-05	0.000508	CcSEcCtD
Acetylsalicylic acid—Anaemia—Gabapentin—epilepsy syndrome	3.95e-05	0.000508	CcSEcCtD
Acetylsalicylic acid—ABCB1—nervous system—epilepsy syndrome	3.95e-05	0.00129	CbGeAlD
Acetylsalicylic acid—Agitation—Gabapentin—epilepsy syndrome	3.93e-05	0.000505	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Phenytoin—epilepsy syndrome	3.93e-05	0.000505	CcSEcCtD
Acetylsalicylic acid—Nausea—Fosphenytoin—epilepsy syndrome	3.92e-05	0.000504	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.91e-05	0.000502	CcSEcCtD
Acetylsalicylic acid—Angioedema—Gabapentin—epilepsy syndrome	3.9e-05	0.000502	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.9e-05	0.000502	CcSEcCtD
Acetylsalicylic acid—Vomiting—Felbamate—epilepsy syndrome	3.89e-05	0.000501	CcSEcCtD
Acetylsalicylic acid—Pruritus—Carbamazepine—epilepsy syndrome	3.88e-05	0.000498	CcSEcCtD
Acetylsalicylic acid—Rash—Felbamate—epilepsy syndrome	3.86e-05	0.000497	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Felbamate—epilepsy syndrome	3.86e-05	0.000496	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Topiramate—epilepsy syndrome	3.85e-05	0.000495	CcSEcCtD
Acetylsalicylic acid—Vertigo—Gabapentin—epilepsy syndrome	3.84e-05	0.000494	CcSEcCtD
Acetylsalicylic acid—Confusional state—Pregabalin—epilepsy syndrome	3.83e-05	0.000493	CcSEcCtD
Acetylsalicylic acid—Flushing—Topiramate—epilepsy syndrome	3.83e-05	0.000493	CcSEcCtD
Acetylsalicylic acid—Syncope—Gabapentin—epilepsy syndrome	3.83e-05	0.000493	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Gabapentin—epilepsy syndrome	3.82e-05	0.000492	CcSEcCtD
Acetylsalicylic acid—Salicylic acid—PTGS2—epilepsy syndrome	3.82e-05	0.0213	CrCbGaD
Acetylsalicylic acid—Dizziness—Clonazepam—epilepsy syndrome	3.82e-05	0.000491	CcSEcCtD
Acetylsalicylic acid—Nausea—Vigabatrin—epilepsy syndrome	3.82e-05	0.000491	CcSEcCtD
Acetylsalicylic acid—Vomiting—Zonisamide—epilepsy syndrome	3.81e-05	0.00049	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Pregabalin—epilepsy syndrome	3.8e-05	0.000489	CcSEcCtD
Acetylsalicylic acid—ABCB1—central nervous system—epilepsy syndrome	3.8e-05	0.00124	CbGeAlD
Acetylsalicylic acid—Dizziness—Phenytoin—epilepsy syndrome	3.79e-05	0.000488	CcSEcCtD
Acetylsalicylic acid—Rash—Zonisamide—epilepsy syndrome	3.78e-05	0.000486	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Zonisamide—epilepsy syndrome	3.78e-05	0.000486	CcSEcCtD
Acetylsalicylic acid—Dizziness—Oxcarbazepine—epilepsy syndrome	3.77e-05	0.000485	CcSEcCtD
Acetylsalicylic acid—Nausea—Diazepam—epilepsy syndrome	3.76e-05	0.000483	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Gabapentin—epilepsy syndrome	3.76e-05	0.000483	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Valproic Acid—epilepsy syndrome	3.75e-05	0.000482	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Carbamazepine—epilepsy syndrome	3.75e-05	0.000482	CcSEcCtD
Acetylsalicylic acid—Pruritus—Lamotrigine—epilepsy syndrome	3.75e-05	0.000482	CcSEcCtD
Acetylsalicylic acid—Shock—Pregabalin—epilepsy syndrome	3.74e-05	0.000481	CcSEcCtD
Acetylsalicylic acid—Somnolence—Valproic Acid—epilepsy syndrome	3.74e-05	0.000481	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Pregabalin—epilepsy syndrome	3.72e-05	0.000479	CcSEcCtD
Acetylsalicylic acid—ABCB1—cerebellum—epilepsy syndrome	3.72e-05	0.00121	CbGeAlD
Acetylsalicylic acid—Tachycardia—Pregabalin—epilepsy syndrome	3.71e-05	0.000477	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Valproic Acid—epilepsy syndrome	3.7e-05	0.000476	CcSEcCtD
Acetylsalicylic acid—Convulsion—Gabapentin—epilepsy syndrome	3.7e-05	0.000476	CcSEcCtD
Acetylsalicylic acid—Hypertension—Gabapentin—epilepsy syndrome	3.69e-05	0.000474	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Pregabalin—epilepsy syndrome	3.68e-05	0.000473	CcSEcCtD
Acetylsalicylic acid—Vomiting—Clonazepam—epilepsy syndrome	3.67e-05	0.000472	CcSEcCtD
Acetylsalicylic acid—Vomiting—Phenytoin—epilepsy syndrome	3.65e-05	0.000469	CcSEcCtD
Acetylsalicylic acid—Rash—Clonazepam—epilepsy syndrome	3.64e-05	0.000468	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Clonazepam—epilepsy syndrome	3.64e-05	0.000468	CcSEcCtD
Acetylsalicylic acid—Chest pain—Gabapentin—epilepsy syndrome	3.64e-05	0.000468	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Gabapentin—epilepsy syndrome	3.64e-05	0.000468	CcSEcCtD
Acetylsalicylic acid—Nausea—Felbamate—epilepsy syndrome	3.64e-05	0.000468	CcSEcCtD
Acetylsalicylic acid—Vomiting—Oxcarbazepine—epilepsy syndrome	3.63e-05	0.000467	CcSEcCtD
Acetylsalicylic acid—Dizziness—Carbamazepine—epilepsy syndrome	3.62e-05	0.000466	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Lamotrigine—epilepsy syndrome	3.62e-05	0.000466	CcSEcCtD
Acetylsalicylic acid—Rash—Phenytoin—epilepsy syndrome	3.62e-05	0.000465	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Phenytoin—epilepsy syndrome	3.61e-05	0.000465	CcSEcCtD
Acetylsalicylic acid—Rash—Oxcarbazepine—epilepsy syndrome	3.6e-05	0.000463	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.6e-05	0.000462	CcSEcCtD
Acetylsalicylic acid—Nausea—Zonisamide—epilepsy syndrome	3.56e-05	0.000458	CcSEcCtD
Acetylsalicylic acid—Confusional state—Gabapentin—epilepsy syndrome	3.52e-05	0.000452	CcSEcCtD
Acetylsalicylic acid—Dizziness—Lamotrigine—epilepsy syndrome	3.5e-05	0.00045	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Gabapentin—epilepsy syndrome	3.49e-05	0.000449	CcSEcCtD
Acetylsalicylic acid—Vomiting—Carbamazepine—epilepsy syndrome	3.48e-05	0.000448	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.47e-05	0.000446	CcSEcCtD
Acetylsalicylic acid—Rash—Carbamazepine—epilepsy syndrome	3.45e-05	0.000444	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Carbamazepine—epilepsy syndrome	3.45e-05	0.000444	CcSEcCtD
Acetylsalicylic acid—Nausea—Clonazepam—epilepsy syndrome	3.43e-05	0.000441	CcSEcCtD
Acetylsalicylic acid—Shock—Gabapentin—epilepsy syndrome	3.43e-05	0.000441	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Gabapentin—epilepsy syndrome	3.41e-05	0.000439	CcSEcCtD
Acetylsalicylic acid—Nausea—Phenytoin—epilepsy syndrome	3.41e-05	0.000438	CcSEcCtD
Acetylsalicylic acid—Salicylic acid—ALB—epilepsy syndrome	3.41e-05	0.019	CrCbGaD
Acetylsalicylic acid—Tachycardia—Gabapentin—epilepsy syndrome	3.4e-05	0.000438	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Pregabalin—epilepsy syndrome	3.39e-05	0.000436	CcSEcCtD
Acetylsalicylic acid—Nausea—Oxcarbazepine—epilepsy syndrome	3.39e-05	0.000436	CcSEcCtD
Acetylsalicylic acid—Somnolence—Pregabalin—epilepsy syndrome	3.38e-05	0.000435	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Gabapentin—epilepsy syndrome	3.37e-05	0.000434	CcSEcCtD
Acetylsalicylic acid—Vomiting—Lamotrigine—epilepsy syndrome	3.37e-05	0.000433	CcSEcCtD
Acetylsalicylic acid—Urticaria—Valproic Acid—epilepsy syndrome	3.34e-05	0.00043	CcSEcCtD
Acetylsalicylic acid—Rash—Lamotrigine—epilepsy syndrome	3.34e-05	0.000429	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Lamotrigine—epilepsy syndrome	3.33e-05	0.000429	CcSEcCtD
Acetylsalicylic acid—Anaemia—Topiramate—epilepsy syndrome	3.32e-05	0.000427	CcSEcCtD
Acetylsalicylic acid—Agitation—Topiramate—epilepsy syndrome	3.3e-05	0.000425	CcSEcCtD
Acetylsalicylic acid—Nausea—Carbamazepine—epilepsy syndrome	3.25e-05	0.000418	CcSEcCtD
Acetylsalicylic acid—Salicylic acid—ABCB1—epilepsy syndrome	3.25e-05	0.0181	CrCbGaD
Acetylsalicylic acid—Vertigo—Topiramate—epilepsy syndrome	3.23e-05	0.000415	CcSEcCtD
Acetylsalicylic acid—Syncope—Topiramate—epilepsy syndrome	3.22e-05	0.000415	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Topiramate—epilepsy syndrome	3.22e-05	0.000414	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Topiramate—epilepsy syndrome	3.16e-05	0.000406	CcSEcCtD
Acetylsalicylic acid—Nausea—Lamotrigine—epilepsy syndrome	3.14e-05	0.000404	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Pregabalin—epilepsy syndrome	3.13e-05	0.000403	CcSEcCtD
Acetylsalicylic acid—Convulsion—Topiramate—epilepsy syndrome	3.11e-05	0.000401	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Gabapentin—epilepsy syndrome	3.11e-05	0.0004	CcSEcCtD
Acetylsalicylic acid—Hypertension—Topiramate—epilepsy syndrome	3.1e-05	0.000399	CcSEcCtD
Acetylsalicylic acid—Somnolence—Gabapentin—epilepsy syndrome	3.1e-05	0.000399	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.1e-05	0.000399	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Gabapentin—epilepsy syndrome	3.07e-05	0.000395	CcSEcCtD
Acetylsalicylic acid—Chest pain—Topiramate—epilepsy syndrome	3.06e-05	0.000394	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Topiramate—epilepsy syndrome	3.06e-05	0.000394	CcSEcCtD
Acetylsalicylic acid—Urticaria—Pregabalin—epilepsy syndrome	3.02e-05	0.000389	CcSEcCtD
Acetylsalicylic acid—ABCB1—brain—epilepsy syndrome	3.02e-05	0.000983	CbGeAlD
Acetylsalicylic acid—Pruritus—Valproic Acid—epilepsy syndrome	2.98e-05	0.000383	CcSEcCtD
Acetylsalicylic acid—Confusional state—Topiramate—epilepsy syndrome	2.96e-05	0.00038	CcSEcCtD
Acetylsalicylic acid—Shock—Topiramate—epilepsy syndrome	2.89e-05	0.000371	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Valproic Acid—epilepsy syndrome	2.88e-05	0.00037	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Gabapentin—epilepsy syndrome	2.87e-05	0.00037	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Topiramate—epilepsy syndrome	2.87e-05	0.000369	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Topiramate—epilepsy syndrome	2.86e-05	0.000368	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Topiramate—epilepsy syndrome	2.84e-05	0.000365	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Pregabalin—epilepsy syndrome	2.8e-05	0.00036	CcSEcCtD
Acetylsalicylic acid—Dizziness—Valproic Acid—epilepsy syndrome	2.78e-05	0.000358	CcSEcCtD
Acetylsalicylic acid—Urticaria—Gabapentin—epilepsy syndrome	2.77e-05	0.000356	CcSEcCtD
Acetylsalicylic acid—Pruritus—Pregabalin—epilepsy syndrome	2.69e-05	0.000346	CcSEcCtD
Acetylsalicylic acid—Vomiting—Valproic Acid—epilepsy syndrome	2.67e-05	0.000344	CcSEcCtD
Acetylsalicylic acid—Rash—Valproic Acid—epilepsy syndrome	2.65e-05	0.000341	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Valproic Acid—epilepsy syndrome	2.65e-05	0.000341	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Topiramate—epilepsy syndrome	2.62e-05	0.000336	CcSEcCtD
Acetylsalicylic acid—Somnolence—Topiramate—epilepsy syndrome	2.61e-05	0.000335	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Pregabalin—epilepsy syndrome	2.6e-05	0.000335	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Topiramate—epilepsy syndrome	2.58e-05	0.000332	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Gabapentin—epilepsy syndrome	2.57e-05	0.00033	CcSEcCtD
Acetylsalicylic acid—Dizziness—Pregabalin—epilepsy syndrome	2.51e-05	0.000323	CcSEcCtD
Acetylsalicylic acid—Nausea—Valproic Acid—epilepsy syndrome	2.5e-05	0.000321	CcSEcCtD
Acetylsalicylic acid—Pruritus—Gabapentin—epilepsy syndrome	2.47e-05	0.000317	CcSEcCtD
Acetylsalicylic acid—Vomiting—Pregabalin—epilepsy syndrome	2.42e-05	0.000311	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Topiramate—epilepsy syndrome	2.42e-05	0.000311	CcSEcCtD
Acetylsalicylic acid—Rash—Pregabalin—epilepsy syndrome	2.4e-05	0.000308	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Pregabalin—epilepsy syndrome	2.4e-05	0.000308	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Gabapentin—epilepsy syndrome	2.39e-05	0.000307	CcSEcCtD
Acetylsalicylic acid—Urticaria—Topiramate—epilepsy syndrome	2.33e-05	0.0003	CcSEcCtD
Acetylsalicylic acid—Dizziness—Gabapentin—epilepsy syndrome	2.31e-05	0.000297	CcSEcCtD
Acetylsalicylic acid—Nausea—Pregabalin—epilepsy syndrome	2.26e-05	0.000291	CcSEcCtD
Acetylsalicylic acid—Vomiting—Gabapentin—epilepsy syndrome	2.22e-05	0.000285	CcSEcCtD
Acetylsalicylic acid—Rash—Gabapentin—epilepsy syndrome	2.2e-05	0.000283	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Gabapentin—epilepsy syndrome	2.2e-05	0.000283	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Topiramate—epilepsy syndrome	2.16e-05	0.000278	CcSEcCtD
Acetylsalicylic acid—Pruritus—Topiramate—epilepsy syndrome	2.08e-05	0.000267	CcSEcCtD
Acetylsalicylic acid—Nausea—Gabapentin—epilepsy syndrome	2.07e-05	0.000266	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Topiramate—epilepsy syndrome	2.01e-05	0.000258	CcSEcCtD
Acetylsalicylic acid—Dizziness—Topiramate—epilepsy syndrome	1.94e-05	0.00025	CcSEcCtD
Acetylsalicylic acid—Vomiting—Topiramate—epilepsy syndrome	1.87e-05	0.00024	CcSEcCtD
Acetylsalicylic acid—Rash—Topiramate—epilepsy syndrome	1.85e-05	0.000238	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Topiramate—epilepsy syndrome	1.85e-05	0.000238	CcSEcCtD
Acetylsalicylic acid—Nausea—Topiramate—epilepsy syndrome	1.74e-05	0.000224	CcSEcCtD
Acetylsalicylic acid—ALB—Hemostasis—NOS2—epilepsy syndrome	1.2e-06	1.56e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	1.2e-06	1.55e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.19e-06	1.55e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.19e-06	1.55e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CASP3—epilepsy syndrome	1.18e-06	1.53e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ADAM10—epilepsy syndrome	1.18e-06	1.53e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.18e-06	1.53e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.17e-06	1.52e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—RELA—epilepsy syndrome	1.17e-06	1.52e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—RELA—epilepsy syndrome	1.17e-06	1.52e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CASP3—epilepsy syndrome	1.17e-06	1.51e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—SRC—epilepsy syndrome	1.17e-06	1.51e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—AQP1—epilepsy syndrome	1.16e-06	1.51e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	1.15e-06	1.5e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	1.15e-06	1.5e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HBEGF—epilepsy syndrome	1.15e-06	1.49e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—MTOR—epilepsy syndrome	1.15e-06	1.49e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—MTOR—epilepsy syndrome	1.15e-06	1.49e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—JUN—epilepsy syndrome	1.15e-06	1.49e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—AKT1—epilepsy syndrome	1.14e-06	1.48e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	1.14e-06	1.48e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.13e-06	1.47e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—JUN—epilepsy syndrome	1.13e-06	1.47e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CYP2D6—epilepsy syndrome	1.13e-06	1.47e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—AKT3—epilepsy syndrome	1.13e-06	1.46e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CHRM3—epilepsy syndrome	1.12e-06	1.46e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	1.12e-06	1.46e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.11e-06	1.45e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—MMP9—epilepsy syndrome	1.11e-06	1.45e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—S100B—epilepsy syndrome	1.11e-06	1.45e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SOCS3—epilepsy syndrome	1.1e-06	1.43e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—MMP9—epilepsy syndrome	1.1e-06	1.43e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CDC42—epilepsy syndrome	1.1e-06	1.43e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—ADAM10—epilepsy syndrome	1.1e-06	1.43e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—FOS—epilepsy syndrome	1.1e-06	1.43e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—ADRA2A—epilepsy syndrome	1.08e-06	1.4e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.07e-06	1.39e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CASP8—epilepsy syndrome	1.07e-06	1.39e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—BCHE—epilepsy syndrome	1.07e-06	1.39e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—AVP—epilepsy syndrome	1.07e-06	1.38e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—AKT1—epilepsy syndrome	1.06e-06	1.38e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—HMOX1—epilepsy syndrome	1.06e-06	1.38e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CASP3—epilepsy syndrome	1.05e-06	1.37e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CASP3—epilepsy syndrome	1.05e-06	1.37e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	1.05e-06	1.37e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.05e-06	1.36e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	1.05e-06	1.36e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	1.05e-06	1.36e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—ABCG2—epilepsy syndrome	1.05e-06	1.36e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—CAT—epilepsy syndrome	1.04e-06	1.36e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—SRC—epilepsy syndrome	1.03e-06	1.34e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CDC42—epilepsy syndrome	1.03e-06	1.33e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	1.02e-06	1.33e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—JUN—epilepsy syndrome	1.02e-06	1.33e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—JUN—epilepsy syndrome	1.02e-06	1.33e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—SLC2A1—epilepsy syndrome	1.02e-06	1.33e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CYP2C19—epilepsy syndrome	1.02e-06	1.32e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	1.02e-06	1.32e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—SRC—epilepsy syndrome	1.02e-06	1.32e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—ABCB1—epilepsy syndrome	1.02e-06	1.32e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CYP11A1—epilepsy syndrome	1.01e-06	1.32e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.01e-06	1.31e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PLCB1—epilepsy syndrome	1.01e-06	1.31e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HES1—epilepsy syndrome	1.01e-06	1.31e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—TH—epilepsy syndrome	1.01e-06	1.31e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.01e-06	1.31e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—VEGFA—epilepsy syndrome	1e-06	1.3e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—MMP9—epilepsy syndrome	9.97e-07	1.29e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—MMP9—epilepsy syndrome	9.97e-07	1.29e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—VEGFA—epilepsy syndrome	9.9e-07	1.29e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—AKT1—epilepsy syndrome	9.88e-07	1.28e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—FYN—epilepsy syndrome	9.8e-07	1.27e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	9.78e-07	1.27e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—H2AFX—epilepsy syndrome	9.77e-07	1.27e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MEF2C—epilepsy syndrome	9.75e-07	1.27e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—FGF2—epilepsy syndrome	9.69e-07	1.26e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—AKT1—epilepsy syndrome	9.67e-07	1.26e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—AKT1—epilepsy syndrome	9.67e-07	1.26e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	9.58e-07	1.24e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—AKT1—epilepsy syndrome	9.54e-07	1.24e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—GPX1—epilepsy syndrome	9.45e-07	1.23e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—YWHAZ—epilepsy syndrome	9.42e-07	1.22e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HES1—epilepsy syndrome	9.4e-07	1.22e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	9.39e-07	1.22e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NGF—epilepsy syndrome	9.32e-07	1.21e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	9.22e-07	1.2e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—BCL2—epilepsy syndrome	9.2e-07	1.2e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	9.19e-07	1.19e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—SRC—epilepsy syndrome	9.19e-07	1.19e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—SRC—epilepsy syndrome	9.19e-07	1.19e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ABCG2—epilepsy syndrome	9.16e-07	1.19e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—FYN—epilepsy syndrome	9.14e-07	1.19e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CYP2D6—epilepsy syndrome	9.14e-07	1.19e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—H2AFX—epilepsy syndrome	9.11e-07	1.18e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	9.09e-07	1.18e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCR5—epilepsy syndrome	9.06e-07	1.18e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	9.02e-07	1.17e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—RELA—epilepsy syndrome	8.99e-07	1.17e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—VEGFA—epilepsy syndrome	8.95e-07	1.16e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—VEGFA—epilepsy syndrome	8.95e-07	1.16e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	8.93e-07	1.16e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	8.87e-07	1.15e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HTR2A—epilepsy syndrome	8.87e-07	1.15e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—AKT1—epilepsy syndrome	8.83e-07	1.15e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—MTOR—epilepsy syndrome	8.82e-07	1.15e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—YWHAZ—epilepsy syndrome	8.79e-07	1.14e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	8.75e-07	1.14e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—BCHE—epilepsy syndrome	8.71e-07	1.13e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—ADRA2A—epilepsy syndrome	8.7e-07	1.13e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—BCHE—epilepsy syndrome	8.66e-07	1.13e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	8.59e-07	1.12e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	8.56e-07	1.11e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	8.46e-07	1.1e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CCR5—epilepsy syndrome	8.46e-07	1.1e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TSC2—epilepsy syndrome	8.43e-07	1.09e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—AGT—epilepsy syndrome	8.42e-07	1.09e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—HMOX1—epilepsy syndrome	8.4e-07	1.09e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	8.34e-07	1.08e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	8.31e-07	1.08e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CAT—epilepsy syndrome	8.29e-07	1.08e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	8.29e-07	1.08e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—AGT—epilepsy syndrome	8.28e-07	1.08e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—SLC2A1—epilepsy syndrome	8.26e-07	1.07e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—APOE—epilepsy syndrome	8.25e-07	1.07e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	8.23e-07	1.07e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	8.23e-07	1.07e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	8.22e-07	1.07e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	8.2e-07	1.07e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—TH—epilepsy syndrome	8.19e-07	1.06e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PLCB1—epilepsy syndrome	8.17e-07	1.06e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—TH—epilepsy syndrome	8.15e-07	1.06e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL1B—epilepsy syndrome	8.13e-07	1.06e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—APOE—epilepsy syndrome	8.11e-07	1.05e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—KDR—epilepsy syndrome	8.08e-07	1.05e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—ABCB1—epilepsy syndrome	8.07e-07	1.05e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	8.06e-07	1.05e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	8.02e-07	1.04e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	8.01e-07	1.04e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—AKT1—epilepsy syndrome	7.98e-07	1.04e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—JUN—epilepsy syndrome	7.88e-07	1.02e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—TSC2—epilepsy syndrome	7.86e-07	1.02e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	7.81e-07	1.01e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—BCHE—epilepsy syndrome	7.78e-07	1.01e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PRKCB—epilepsy syndrome	7.78e-07	1.01e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL6ST—epilepsy syndrome	7.74e-07	1.01e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—APOE—epilepsy syndrome	7.69e-07	9.99e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	7.64e-07	9.92e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	7.62e-07	9.9e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—BCHE—epilepsy syndrome	7.59e-07	9.86e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—AKT1—epilepsy syndrome	7.54e-07	9.8e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	7.5e-07	9.75e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—GPX1—epilepsy syndrome	7.5e-07	9.74e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	7.48e-07	9.72e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	7.42e-07	9.64e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	7.34e-07	9.53e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—TH—epilepsy syndrome	7.31e-07	9.5e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	7.24e-07	9.41e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—AKT1—epilepsy syndrome	7.24e-07	9.41e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—IL6ST—epilepsy syndrome	7.22e-07	9.39e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	7.2e-07	9.35e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NOS2—epilepsy syndrome	7.17e-07	9.31e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PLCB1—epilepsy syndrome	7.16e-07	9.3e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—TH—epilepsy syndrome	7.14e-07	9.27e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—SRC—epilepsy syndrome	7.12e-07	9.25e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	7.12e-07	9.25e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—BCHE—epilepsy syndrome	7.09e-07	9.21e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—POMC—epilepsy syndrome	7.08e-07	9.2e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—SRC—epilepsy syndrome	7.07e-07	9.18e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—POMC—epilepsy syndrome	6.97e-07	9.06e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—VEGFA—epilepsy syndrome	6.94e-07	9.01e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCL2—epilepsy syndrome	6.93e-07	9e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	6.84e-07	8.88e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—HMOX1—epilepsy syndrome	6.8e-07	8.83e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	6.76e-07	8.79e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CAT—epilepsy syndrome	6.75e-07	8.76e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CAT—epilepsy syndrome	6.71e-07	8.71e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	6.69e-07	8.69e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—TH—epilepsy syndrome	6.67e-07	8.66e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—AGT—epilepsy syndrome	6.57e-07	8.54e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	6.56e-07	8.53e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	6.56e-07	8.53e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—ABCB1—epilepsy syndrome	6.53e-07	8.48e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—APOE—epilepsy syndrome	6.44e-07	8.37e-06	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—AKT1—epilepsy syndrome	6.39e-07	8.3e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—ALB—epilepsy syndrome	6.36e-07	8.26e-06	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—AKT1—epilepsy syndrome	6.31e-07	8.2e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—FGF2—epilepsy syndrome	6.26e-07	8.14e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	6.1e-07	7.93e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GPX1—epilepsy syndrome	6.1e-07	7.93e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GPX1—epilepsy syndrome	6.07e-07	7.88e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CAT—epilepsy syndrome	6.02e-07	7.82e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—HMOX1—epilepsy syndrome	5.96e-07	7.74e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CAT—epilepsy syndrome	5.88e-07	7.63e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	5.86e-07	7.61e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—FGF2—epilepsy syndrome	5.84e-07	7.59e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—RELA—epilepsy syndrome	5.81e-07	7.55e-06	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—AKT1—epilepsy syndrome	5.71e-07	7.42e-06	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—AKT1—epilepsy syndrome	5.71e-07	7.42e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MTOR—epilepsy syndrome	5.7e-07	7.41e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	5.56e-07	7.23e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PTGS2—epilepsy syndrome	5.56e-07	7.22e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—POMC—epilepsy syndrome	5.53e-07	7.19e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CAT—epilepsy syndrome	5.49e-07	7.13e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GPX1—epilepsy syndrome	5.45e-07	7.07e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—AGT—epilepsy syndrome	5.35e-07	6.95e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	5.34e-07	6.94e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MTOR—epilepsy syndrome	5.32e-07	6.91e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—AGT—epilepsy syndrome	5.32e-07	6.91e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GPX1—epilepsy syndrome	5.32e-07	6.9e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CASP3—epilepsy syndrome	5.24e-07	6.81e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—APOE—epilepsy syndrome	5.24e-07	6.81e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—APOE—epilepsy syndrome	5.21e-07	6.77e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—JUN—epilepsy syndrome	5.09e-07	6.62e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—ALB—epilepsy syndrome	5.05e-07	6.55e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GPX1—epilepsy syndrome	4.97e-07	6.45e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MMP9—epilepsy syndrome	4.96e-07	6.44e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—AGT—epilepsy syndrome	4.78e-07	6.2e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—APOE—epilepsy syndrome	4.68e-07	6.08e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—AGT—epilepsy syndrome	4.66e-07	6.05e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SRC—epilepsy syndrome	4.57e-07	5.94e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—APOE—epilepsy syndrome	4.57e-07	5.93e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—POMC—epilepsy syndrome	4.5e-07	5.85e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—POMC—epilepsy syndrome	4.48e-07	5.82e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—VEGFA—epilepsy syndrome	4.45e-07	5.78e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—AKT1—epilepsy syndrome	4.43e-07	5.75e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—AKT1—epilepsy syndrome	4.39e-07	5.71e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—AGT—epilepsy syndrome	4.35e-07	5.66e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—APOE—epilepsy syndrome	4.27e-07	5.54e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—SRC—epilepsy syndrome	4.26e-07	5.54e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ALB—epilepsy syndrome	4.11e-07	5.33e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—POMC—epilepsy syndrome	4.02e-07	5.22e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—POMC—epilepsy syndrome	3.92e-07	5.1e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—POMC—epilepsy syndrome	3.66e-07	4.76e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ALB—epilepsy syndrome	3.66e-07	4.76e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	3.59e-07	4.67e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ALB—epilepsy syndrome	3.58e-07	4.65e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PTGS2—epilepsy syndrome	3.57e-07	4.64e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ALB—epilepsy syndrome	3.34e-07	4.34e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	3.21e-07	4.16e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PTGS2—epilepsy syndrome	3.13e-07	4.06e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	2.92e-07	3.8e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—AKT1—epilepsy syndrome	2.84e-07	3.69e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—AKT1—epilepsy syndrome	2.79e-07	3.63e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—AKT1—epilepsy syndrome	2.65e-07	3.44e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—AKT1—epilepsy syndrome	2.22e-07	2.88e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—AKT1—epilepsy syndrome	1.81e-07	2.34e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—AKT1—epilepsy syndrome	1.79e-07	2.33e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—AKT1—epilepsy syndrome	1.61e-07	2.09e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—AKT1—epilepsy syndrome	1.57e-07	2.04e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—AKT1—epilepsy syndrome	1.47e-07	1.91e-06	CbGpPWpGaD
